Membrane-Free Lateral Flow Assay with the Active Control of Fluid Transport for Ultrasensitive Cardiac Biomarker Detection

URN to cite this document:: urn:nbn:de:bvb:355-epub-582890
DOI to cite this document:: 10.5283/epub.58289

Strohmaier-Nguyen, Dan

; Horn, Carina ; Baeumner, Antje J.

License: Creative Commons Attribution 4.0
PDF - Published Version
(3MB)

Date of publication of this fulltext: 17 May 2024 17:44

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Membrane-based lateral flow immunoassays (LFAs) have been employed as early point-of-care (POC) testing tools in clinical settings. However, the varying membrane properties, uncontrollable sample transport in LFAs, visual readout, and required large sample volumes have been major limiting factors in realizing needed sensitivity and desirable precise quantification. Addressing these challenges, we ...